NewsMarkets

Health

Pancreatic Cancer Pill Daraxonrasib Shows Major Breakthrough in Trial

The drug daraxonrasib caused tumors to stop growing in nearly all participants and became undetectable in one in twelve patients during a recent trial.

4 publishers · 4 articles · first seen 20 Nov 2026 · updated 16h ago

Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made

The story so far

4 publishers have covered this in 4 articles since 20 Nov 2026. BBC Health published first, on 20 November at 00:08 UTC; The Guardian followed 9h 28m later. The most recent article, from MedPageToday.com - medical news for physicians, appeared on 20 November at 20:15 UTC.

Outlets reporting it: The Guardian (major outlet), News Feed (major outlet), BBC Health, MedPageToday.com - medical news for physicians.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. New pancreatic cancer drug halts tumour growth in 90% of patients News Feed ·
  2. Pill to treat pancreatic cancer hailed as ‘biggest breakthrough in decades’ The Guardian ·
  3. 'Grand Slam' Pancreatic Cancer Drug Shows Promise as First-Line Treatment MedPageToday.com - medical news for physicians
  4. Massive hope for pancreatic cancer pill after trial saw tumours vanish BBC Health

In this story

  • daraxonrasib
Embed this story

Paste this into any web page to show the live odds, with a link back here.